Correlation OF Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans - Full Text View

Sponsored by:	North Shore Long Island Jewish Health System
Information provided by:	North Shore Long Island Jewish Health System
ClinicalTrials.gov Identifier:	NCT00621075

Purpose

The goal of our study is to correlate data from non-invasive tests such as perfusion lung scans with hemodynamic measurements from right heart catherizations.

Condition	Intervention
Pulmonary Arterial Hypertension	Other: Pulmonary Arterial Hypertension - Lung Perfusion Scans

Genetics Home Reference related topics: pulmonary arterial hypertension

MedlinePlus related topics: High Blood Pressure Nuclear Scans Pulmonary Hypertension

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Retrospective
Official Title:	Correlation of Hemodynamics in Pulmonary Hypertension With Perfusion Lung Scans

Further study details as provided by North Shore Long Island Jewish Health System:

Primary Outcome Measures:

The correlation of patients' hemodynamic parameters with their perfusion index/pulmonary index as measured by ventilation perfusion scans in patients diagnosed with Pulmonary Hypertension. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	50
Study Start Date:	April 2007
Study Completion Date:	February 2008
Primary Completion Date:	February 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 Pulmonary Arterial Hypertension	Other: Pulmonary Arterial Hypertension - Lung Perfusion Scans Correlation of data from non-invasive tests such as lung perfusion scans with hemodynamic measurements

Detailed Description:

Data collected from PAH patients who have had non-invasive Ventilation/Perfusion testing, Echocardiography, Chest CT Scan, Pulmonary Function Testing and the correlation of those results to the hemodynamic parameters Right Heart Catherization results and the various biomarkers.

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Pulmonary Arterial Hypertension

Criteria

Inclusion Criteria:

Pulmonary Arterial Hypertension

Exclusion Criteria:

Non-Pulmonary Arterial Hypertension

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00621075

Locations

United States, New York
North Shore-Lij Health System
NEW HYDE PARK, New York, United States, 11040

Sponsors and Collaborators

North Shore Long Island Jewish Health System

Investigators

Principal Investigator:

ARUNABH TALWAR, MD

NORTH SHORE-LIJ HEALTH SYSTEM

More Information

Responsible Party:	NORTH SHORE-LONG ISLAND JEWIAH HEALTH SYSTEM ( ARUNABH TALWAR MD )
Study ID Numbers:	07.014, NORTH SHORE IRB
Study First Received:	January 17, 2008
Last Updated:	January 12, 2009
ClinicalTrials.gov Identifier:	NCT00621075
Health Authority:	United States: Institutional Review Board

Keywords provided by North Shore Long Island Jewish Health System:

PAH; V/Q SCAN;RHC;Echo;CT Scans; Angiography;PFTs

Study placed in the following topic categories:

Idiopathic pulmonary hypertension
Respiratory Tract Diseases
Hypertension, Pulmonary

Lung Diseases
Vascular Diseases
Hypertension

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009